Antibiotic is one of 355 small molecule programs targeting Indocyanine Green (ICG). It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
348 competitors in Prostate Cancer
Cabometyx
Talzenna
Glucophage
Antibiotic
Lhrha
Docetaxel /m²
Luteinizing Hormone Releasing Hormone
Fuzuloparib
Trexall
Botox
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources